Preadmission glycemic control and changes to diabetes mellitus treatment regimen after hospitalization

Endocrine Practice

Volumn 18, Issue 3, 2012, Pages 371-375

  Bergenstal, Richard M ^a   Fahrbach, Jessie L ^b   Iorga, Şerban R ^c   Fan, Ying ^c   Foster, Shonda A ^b  

^a INTERNATIONAL DIABETES CENTER   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c OPTUM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; HEMOGLOBIN A1C; INSULIN; PRAMLINTIDE;

ADULT; ARTICLE; DATA BASE; DIABETES MELLITUS; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TREATMENT PLANNING; TREATMENT RESPONSE;

AGED; AMBULATORY CARE; COHORT STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84861077592     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11166.OR     Document Type: Article

References (13)

1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet, 2011. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2011. Available at: Http://www.cdc.gov/diabetes/ pubs/factsheet11.htm. Accessed for verification February 24, 2012.
2. National Institute of Diabetes and Digestive and Kidney Diseases. National diabetes statistics, 2007 fact sheet. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health; 2008 http://diabe-tes.niddk.nih.gov/dm/pubs/statistics/index.aspx.
3. American Diabetes Association. Economic costs of dia-betes in the U.S. In 2007. Diabetes Care. 2008;31:596-615.
4. Rodbard HW, Blonde L, Braithwaite SS, et al; AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13(Suppl 1):1-68.
5. American Diabetes Association. Executive summary: Standards of medical care in diabetes-2011. Diabetes Care. 2011;34(Suppl 1):S4-S10.
6. Health Insurance Portability and Accountability Act. Pub L No. 104-191, 104th Congress (1996) Available at: Http://www.cms.hhs.gov/HIPAAGenInfo/ Downloads/HIPAALaw.pdf.
7. Resnick HE, Foster GL, Bardsley J, Ratner RE. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabe-tes, 1999-2002: The National Health and Nutrition Exami-nation Survey. Diabetes Care. 2006;29(3):531-537.
8. Brown JB, Nichols GA. Slow response to loss of glyce-mic control in type 2 diabetes mellitus. Am J Manag Care. 2003;9:213-217.
9. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group (Er-ratum in: Lancet. 1999;354:602).
10. Lancet. 1998;352:837-853.
11. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-1589.
12. The effect of intensive treatment of diabetes on the de-velopment and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-986.
13. Zoungas S, de Galan BE, Ninomiya T, et al; ADVANCE Collaborative Group. Combined effects of routine blood pressure lowering and intensive glucose control on macro-vascular and microvascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial. Diabetes Care. 2009;32:2068-2074.